Investors who hold or have bought CTSO stock at the close of Nasdaq trading ... on our balance sheet on a dollar-for-dollar basis. For example, aggregate proceeds of $5.0 million would result ...

13, 2025 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood ...